After several months of consultation and involvement with your Product Compliance and Market Access Committee, we are pleased the Natural and Non-prescription Health Products Directorate (NNHPD) has published two […]
The Consumer & Hazardous Products Safety Directorate (CHPSD) has published the 2025 Consultation on Proposed Updates to the Cosmetic Ingredient Hotlist on November 19, 2025. The consultation will close […]
Please find below NNHPD’s official announcement on the Web PLA and ANF Form being temporarily unavailable from December 1st to December 15th. NNHPD’s Official Announcement
Cosmetics Alliance has been informed by the Natural & Non-prescription Health Products Directorate (NNHPD) that major changes are coming to the Product Licence Application (PLA) process for Class II […]
This week, Environment and Climate Change Canada (ECCC) announced that the Integrated Chemical Mixtures Project (ICMP) web-site is live. Launched in 2023, the ICMP is an initiative to investigate […]
The Health Product Compliance Directorate is advising you of a change in reporting expectations to Health Canada when nitrosamine impurities are detected in drug products marketed in Canada. […]
Health Canada is proposing significant amendments to the Medical Devices Regulations (MDR) to modernize the MDEL framework, aiming to streamline processes, enhance international alignment, and improve supply chain oversight. […]
Health Canada initially proposed new fees for Natural Health Products (NHPs) in May 2023, and after public consultation, revised the proposal in March 2024, indicating a seven-year phase-in period […]
Following discussions at the October 9, 2025, Multilateral Stakeholder meeting on Natural Health Products (NHPs) and Non-prescription Drugs (NPDs), the Natural and Non-prescription Health Products Directorate (NNHPD) has implemented […]
PRODUCT LICENSING: The NNHPD has returned to meeting its performance standards for new and post-licensing Class I and II applications. There are approximately 4150 files in Class III […]
